Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

Immunotherapy is a promising area of therapy in patients with neuro-oncological malignancies. However, early-phase studies show unique challenges associated with the assessment of radiological changes in response to immunotherapy reflecting delayed responses or therapy-induced inflammation. Clinical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Okada, Hideho (VerfasserIn) , Weller, Michael (VerfasserIn) , Huang, Raymond (VerfasserIn) , Finocchiaro, Gaetano (VerfasserIn) , Gilbert, Mark R (VerfasserIn) , Wick, Wolfgang (VerfasserIn) , Ellingson, Benjamin M (VerfasserIn) , Hashimoto, Naoya (VerfasserIn) , Pollack, Ian F (VerfasserIn) , Brandes, Alba A (VerfasserIn) , Franceschi, Enrico (VerfasserIn) , Herold-Mende, Christel (VerfasserIn) , Nayak, Lakshmi (VerfasserIn) , Panigrahy, Ashok (VerfasserIn) , Pope, Whitney B (VerfasserIn) , Prins, Robert (VerfasserIn) , Sampson, John H (VerfasserIn) , Wen, Patrick Y (VerfasserIn) , Reardon, David A (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2 November 2015
In: The lancet. Oncology
Year: 2015, Jahrgang: 16, Heft: 15, Pages: e534-e542
ISSN:1474-5488
DOI:10.1016/S1470-2045(15)00088-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S1470-2045(15)00088-1
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S1470204515000881
Volltext
Verfasserangaben:Hideho Okada, Michael Weller, Raymond Huang, Gaetano Finocchiaro, Mark R Gilbert, Wolfgang Wick, Benjamin M Ellingson, Naoya Hashimoto, Ian F Pollack, Alba A Brandes, Enrico Franceschi, Christel Herold-Mende, Lakshmi Nayak, Ashok Panigrahy, Whitney B Pope, Robert Prins, John H Sampson, Patrick Y Wen, David A Reardon

MARC

LEADER 00000caa a2200000 c 4500
001 1701921537
003 DE-627
005 20220818130413.0
007 cr uuu---uuuuu
008 200623s2015 xx |||||o 00| ||eng c
024 7 |a 10.1016/S1470-2045(15)00088-1  |2 doi 
035 |a (DE-627)1701921537 
035 |a (DE-599)KXP1701921537 
035 |a (OCoLC)1341340953 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Okada, Hideho  |e VerfasserIn  |0 (DE-588)1212443985  |0 (DE-627)1701924099  |4 aut 
245 1 0 |a Immunotherapy response assessment in neuro-oncology  |b a report of the RANO working group  |c Hideho Okada, Michael Weller, Raymond Huang, Gaetano Finocchiaro, Mark R Gilbert, Wolfgang Wick, Benjamin M Ellingson, Naoya Hashimoto, Ian F Pollack, Alba A Brandes, Enrico Franceschi, Christel Herold-Mende, Lakshmi Nayak, Ashok Panigrahy, Whitney B Pope, Robert Prins, John H Sampson, Patrick Y Wen, David A Reardon 
264 1 |c 2 November 2015 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.06.2020 
520 |a Immunotherapy is a promising area of therapy in patients with neuro-oncological malignancies. However, early-phase studies show unique challenges associated with the assessment of radiological changes in response to immunotherapy reflecting delayed responses or therapy-induced inflammation. Clinical benefit, including long-term survival and tumour regression, can still occur after initial disease progression or after the appearance of new lesions. Refinement of the response assessment criteria for patients with neuro-oncological malignancies undergoing immunotherapy is therefore warranted. Herein, a multinational and multidisciplinary panel of neuro-oncology immunotherapy experts describe immunotherapy Response Assessment for Neuro-Oncology (iRANO) criteria based on guidance for the determination of tumour progression outlined by the immune-related response criteria and the RANO working group. Among patients who demonstrate imaging findings meeting RANO criteria for progressive disease within 6 months of initiating immunotherapy, including the development of new lesions, confirmation of radiographic progression on follow-up imaging is recommended provided that the patient is not significantly worse clinically. The proposed criteria also include guidelines for the use of corticosteroids. We review the role of advanced imaging techniques and the role of measurement of clinical benefit endpoints including neurological and immunological functions. The iRANO guidelines put forth in this Review will evolve successively to improve their usefulness as further experience from immunotherapy trials in neuro-oncology accumulate. 
700 1 |a Weller, Michael  |e VerfasserIn  |4 aut 
700 1 |a Huang, Raymond  |e VerfasserIn  |4 aut 
700 1 |a Finocchiaro, Gaetano  |e VerfasserIn  |4 aut 
700 1 |a Gilbert, Mark R  |e VerfasserIn  |4 aut 
700 1 |a Wick, Wolfgang  |d 1970-  |e VerfasserIn  |0 (DE-588)120297736  |0 (DE-627)080586929  |0 (DE-576)186221320  |4 aut 
700 1 |a Ellingson, Benjamin M  |e VerfasserIn  |4 aut 
700 1 |a Hashimoto, Naoya  |e VerfasserIn  |4 aut 
700 1 |a Pollack, Ian F  |e VerfasserIn  |4 aut 
700 1 |a Brandes, Alba A  |e VerfasserIn  |4 aut 
700 1 |a Franceschi, Enrico  |e VerfasserIn  |4 aut 
700 1 |a Herold-Mende, Christel  |e VerfasserIn  |0 (DE-588)1022936549  |0 (DE-627)717335577  |0 (DE-576)366194267  |4 aut 
700 1 |a Nayak, Lakshmi  |e VerfasserIn  |4 aut 
700 1 |a Panigrahy, Ashok  |e VerfasserIn  |4 aut 
700 1 |a Pope, Whitney B  |e VerfasserIn  |4 aut 
700 1 |a Prins, Robert  |e VerfasserIn  |4 aut 
700 1 |a Sampson, John H  |e VerfasserIn  |4 aut 
700 1 |a Wen, Patrick Y  |e VerfasserIn  |4 aut 
700 1 |a Reardon, David A  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t The lancet. Oncology  |d London : The Lancet Publ. Group, 2000  |g 16(2015), 15, Seite e534-e542  |h Online-Ressource  |w (DE-627)325349770  |w (DE-600)2035574-9  |w (DE-576)100517544  |x 1474-5488  |7 nnas  |a Immunotherapy response assessment in neuro-oncology a report of the RANO working group 
773 1 8 |g volume:16  |g year:2015  |g number:15  |g pages:e534-e542  |g extent:9  |a Immunotherapy response assessment in neuro-oncology a report of the RANO working group 
856 4 0 |u https://doi.org/10.1016/S1470-2045(15)00088-1  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1470204515000881  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200623 
993 |a Article 
994 |a 2015 
998 |g 1022936549  |a Herold-Mende, Christel  |m 1022936549:Herold-Mende, Christel  |d 910000  |d 911200  |e 910000PH1022936549  |e 911200PH1022936549  |k 0/910000/  |k 1/910000/911200/  |p 12 
998 |g 120297736  |a Wick, Wolfgang  |m 120297736:Wick, Wolfgang  |d 910000  |d 911100  |e 910000PW120297736  |e 911100PW120297736  |k 0/910000/  |k 1/910000/911100/  |p 6 
999 |a KXP-PPN1701921537  |e 3690347238 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"note":["Gesehen am 23.06.2020"],"person":[{"given":"Hideho","display":"Okada, Hideho","role":"aut","family":"Okada"},{"given":"Michael","role":"aut","family":"Weller","display":"Weller, Michael"},{"display":"Huang, Raymond","family":"Huang","role":"aut","given":"Raymond"},{"display":"Finocchiaro, Gaetano","family":"Finocchiaro","role":"aut","given":"Gaetano"},{"given":"Mark R","role":"aut","family":"Gilbert","display":"Gilbert, Mark R"},{"role":"aut","family":"Wick","display":"Wick, Wolfgang","given":"Wolfgang"},{"given":"Benjamin M","display":"Ellingson, Benjamin M","role":"aut","family":"Ellingson"},{"display":"Hashimoto, Naoya","role":"aut","family":"Hashimoto","given":"Naoya"},{"given":"Ian F","family":"Pollack","role":"aut","display":"Pollack, Ian F"},{"display":"Brandes, Alba A","role":"aut","family":"Brandes","given":"Alba A"},{"given":"Enrico","display":"Franceschi, Enrico","role":"aut","family":"Franceschi"},{"given":"Christel","role":"aut","family":"Herold-Mende","display":"Herold-Mende, Christel"},{"given":"Lakshmi","role":"aut","family":"Nayak","display":"Nayak, Lakshmi"},{"family":"Panigrahy","role":"aut","display":"Panigrahy, Ashok","given":"Ashok"},{"display":"Pope, Whitney B","role":"aut","family":"Pope","given":"Whitney B"},{"given":"Robert","role":"aut","family":"Prins","display":"Prins, Robert"},{"family":"Sampson","role":"aut","display":"Sampson, John H","given":"John H"},{"display":"Wen, Patrick Y","family":"Wen","role":"aut","given":"Patrick Y"},{"given":"David A","family":"Reardon","role":"aut","display":"Reardon, David A"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1016/S1470-2045(15)00088-1"],"eki":["1701921537"]},"recId":"1701921537","name":{"displayForm":["Hideho Okada, Michael Weller, Raymond Huang, Gaetano Finocchiaro, Mark R Gilbert, Wolfgang Wick, Benjamin M Ellingson, Naoya Hashimoto, Ian F Pollack, Alba A Brandes, Enrico Franceschi, Christel Herold-Mende, Lakshmi Nayak, Ashok Panigrahy, Whitney B Pope, Robert Prins, John H Sampson, Patrick Y Wen, David A Reardon"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2 November 2015"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1474-5488"],"zdb":["2035574-9"],"eki":["325349770"]},"recId":"325349770","origin":[{"publisher":"The Lancet Publ. Group","dateIssuedDisp":"2000-","publisherPlace":"London","dateIssuedKey":"2000"}],"disp":"Immunotherapy response assessment in neuro-oncology a report of the RANO working groupThe lancet. Oncology","language":["eng"],"pubHistory":["0.2000 -"],"titleAlt":[{"title":"The lancet <London> / Oncology"}],"note":["Gesehen am 22.09.2021"],"part":{"extent":"9","year":"2015","pages":"e534-e542","issue":"15","text":"16(2015), 15, Seite e534-e542","volume":"16"},"title":[{"title_sort":"lancet","partname":"Oncology","title":"The lancet"}],"physDesc":[{"extent":"Online-Ressource"}]}],"title":[{"title_sort":"Immunotherapy response assessment in neuro-oncology","subtitle":"a report of the RANO working group","title":"Immunotherapy response assessment in neuro-oncology"}],"physDesc":[{"extent":"9 S."}]} 
SRT |a OKADAHIDEHIMMUNOTHER2201